Skip to main content
. 2022 Oct 29;14(21):5330. doi: 10.3390/cancers14215330

Table 1.

Sensitivity profile of different molecular subtypes of KIT or PDGFRA GISTs.

Molecular GIST Sub-Type Treatment
Imatinib [14,31,43] Sunitinib [45] Regorafenib [53] Ripretinib [50] Avapritinib [51]
KIT Mutations
Exon 9 - - - -
Exon 11 - - - -
Exon 13 (V654) -
Exon 14 (T670) -
Exon 17 (D816) ✓/✕ ✓/✕ -
Exon 17 (D820) -
Exon 17 (N822) -
Exon 17 (Y823) -
Exon 18 (A829) -
PDGFRA Mutations
Exon 12
Exon 13
Exon 14
Exon 15
Exon 18 (D842V)
Exon 18 (Non-D842V)

The checkmarks indicate drug sensitivity, and the crosses indicate drug resistance.